Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an <i>In Silico</i> Drug Repurposing Approach-Reference-Cited by-同舟云学术

Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach

Published:2023-05-25 Issue:11 Volume:63 Page:3601-3613
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Ambrosio Francesca Alessandra¹^ORCID,Costa Giosuè²³^ORCID,Romeo Isabella²³^ORCID,Esposito Francesca⁴,Alkhatib Mohammad⁵,Salpini Romina⁵,Svicher Valentina⁵,Corona Angela⁴^ORCID,Malune Paolo⁴,Tramontano Enzo⁴^ORCID,Ceccherini-Silberstein Francesca⁵,Alcaro Stefano²³^ORCID,Artese Anna²³

Affiliation:

1. Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi “Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy

2. Dipartimento di Scienze della Salute, Università degli Studi “Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy

3. Net4Science Academic Spin-Off, Università degli Studi “Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy

4. Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, 09124 Cagliari, Italy

5. Dipartimento di Medicina Sperimentale, Università degli Studi di Roma “Tor Vergata”, Via Montpellier, 1, 00133 Roma, Italy

Funder

Regione Calabria

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.3c00282

Reference65 articles.

1. WHO COVID-19 Dashboard. World Health Organization: Geneva, 2020. Available online. https://covid19.who.int/ (accessed September 15, 2022).

2. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update

3. Coronaviruses: An Overview of Their Replication and Pathogenesis

4. COVID-19: Drug Targets and Potential Treatments

5. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents;Biomolecules;2024-07-04

2. New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors;Pharmaceuticals;2024-05-17

3. Crystal structure of SARS-CoV-2 main protease (Mpro) mutants in complex with the non-covalent inhibitor CCF0058981;Biochemical and Biophysical Research Communications;2024-01

4. Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment;Experimental Biology and Medicine;2023-11-24

5. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing;Biomedicine & Pharmacotherapy;2023-11